Relapse prevalence, symptoms, and health care engagement: Patient insights from the Multiple Sclerosis In America 2017 survey

Authors: Tara Nazareth¹, Jackie Polyakov¹, Ed Banfe¹, Kristine Zerkowski², Leslie Beth Herbert²

Partnering with Mallinckrodt Pharmaceuticals, this abstract was published in November 2017 showcasing data from Health Union’s syndicated research study Multiple Sclerosis In America 2017.

The aim of this survey is to obtain direct insight into relapse prevalence, symptoms, and HCP engagement from patients with MS who responded to the Multiple Sclerosis in America (MSIA) 2017 survey.

Read the article on ScienceDirect.

¹Mallinckrodt Pharmaceuticals, external partner
²Health Union, LLC

Relapse prevalence, symptoms, and health care engagement: Patient insights from the Multiple Sclerosis In America 2017 survey

Contact